Evaluating Safety of Transpulmonary Pressure Guided PEEP Management in Neurocritical Care Patients



Status:Recruiting
Conditions:High Blood Pressure (Hypertension), Neurology, Pulmonary
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:3/7/2019
Start Date:March 1, 2019
End Date:September 30, 2019

Use our guide to learn which trials are right for you!

We aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in
patients with possible elevations of intracranial pressure.

Purpose: To establish safety of titrating PEEP based on transpulmonary pressure as measured
by an esophageal balloon in mechanically ventilated neurosurgical patients.

Participants: Adult patients admitted to the Neuro ICU at UNC Hospital and requiring
mechanical ventilation who have an intracranial pressure monitoring device in place.

Procedures (methods): All enrolled patients will have esophageal balloons placed with
measurement of transpulmonary pressures. All patients will have baseline measurements
recorded of intracranial pressure, cerebral perfusion pressure, and cerebral autoregulation.
PEEP will then be titrated based on transpulmonary pressure measurements with recording of
physiological measurements over the next hour. At the conclusion of the hour, all patients
will be returned to their prior ventilator settings.

Inclusion Criteria:

- Adult patients (age >/= 18) admitted to the Neuro ICU of UNC Hospital requiring
mechanical ventilation and with ICP monitoring in place.

Exclusion Criteria:

1. Pneumothorax or pneumomediastinum

2. Life expectancy < 24 hours or expected to require mechanical ventilation for < 24
hours

3. Condition that precludes placement of an esophageal balloon [esophageal or
nasopharyngeal pathology preventing insertion of the esophageal balloon catheter
(esophageal ulcerations, tumors, diverticulitis, bleeding varices or in patients with
sinusitis, epistaxis or recent nasopharyngeal surgery), severe thrombocytopenia
(platelet count < 30) or coagulopathy (INR > 3 or on oral anticoagulants).

4. Pre-enrollment ICP > 20 mm Hg

5. Pre-enrollment CPP < 60 mm Hg

6. Planned change in the external ventricular drain set point during the
pre-intervention, intervention or post-intervention periods

7. Incarceration

8. Variation in ICP of > 2 cm H2O in the hour prior to intervention.
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
Phone: 919-966-2531
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials